Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Hepatitis

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 42 articles: HTML format

Single Articles

May 2025
1. HALL EW, Sandul AL, Kamili S, Cartwright EJ, et al
   Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C Among US Adults.
   Clin Infect Dis. 2025 May 21:ciaf166. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. KU JH, Gu YM, Hoke CF, Tseng HF, et al
   Screening and vaccination rates for tetanus, hepatitis A, and hepatitis B among individuals with substance use disorders who are hospitalized in an integrated U.S. health system.
   Clin Infect Dis. 2025 May 20:ciaf251. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2025
3. SHEMUEL J, Krawiec A, Kalauokalani D, Lucas KD, et al
   A Case-Control Study of Hepatitis C Virus Re-infection in Incarcerated Patients in California Receiving Medication for Opioid Use Disorder.
   Clin Infect Dis. 2025 Apr 15:ciaf192. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. THOMAS AM, Litwin AH, Tsui JI, Sprecht-Walsh S, et al
   Retreatment of Hepatitis C Virus Among People Who Inject Drugs.
   Clin Infect Dis. 2025 Apr 15:ciaf082. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. CARSON JM, Dore GJ
   Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who Inject Drugs.
   Clin Infect Dis. 2025 Apr 15:ciaf083. doi: 10.1093.
   PubMed    
   
   
   
6. TOY M, Hutton D, Teshale E, Thompson WW, et al
   Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States.
   Clin Infect Dis. 2025 Apr 8:ciaf181. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2025
7. AZZELLINO G, Ginaldi L, De Martinis M
   A Biosocial Roadmap to Tackle the Burden of Hepatitis C Virus Infections That Ensures Health Equity for All.
   Clin Infect Dis. 2025 Feb 12:ciae623. doi: 10.1093.
   PubMed    
   
   
   January 2025
8. SERUMONDO J, Barebwanuwe P, Sheferaw ED, Iyonizera J, et al
   Introducing Sofosbuvir/Velpatasvir + Ribavirin as a Generic Retreatment Regimen for Hepatitis C: Evaluation of a Government Program in Rwanda.
   Clin Infect Dis. 2025 Jan 29:ciae637. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. BARRE T, Ramier C, Wittkop L, Sogni P, et al
   Low CD4 cell count is associated with post-hepatitis C virus cure mortality in people living with HIV (ANRS CO13 HEPAVIH cohort).
   Clin Infect Dis. 2025 Jan 15:ciaf016. doi: 10.1093.
   PubMed    
   
   
   
10. MATELSKI A, Gregoire B, Beste LA, Varley CD, et al
    Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of U.S. Veterans.
    Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. HUANG YS, Sun HY, Ho SY, Lin KY, et al
    Incidence and outcome of hepatitis D virus infection in people with HIV in the era of tenofovir-containing antiretroviral therapy.
    Clin Infect Dis. 2025 Jan 2:ciae655. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
12. HAN WM, Solomon S, Smeaton L, Avihingsanon A, et al
    Reinfection and resistance associated substitutions following a minimal monitoring approach for HCV treatment in MINMON trial.
    Clin Infect Dis. 2024 Dec 20:ciae627. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. CHAPPELL CA, Kiser JJ, Brooks KM, Randolph R, et al
    Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus.
    Clin Infect Dis. 2024 Dec 17:ciae595. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
14. SEAMAN A, Cook R, Leichtling G, Herink MC, et al
    Peer-assisted telemedicine for hepatitis C in people who use drugs: A randomized controlled trial.
    Clin Infect Dis. 2024 Nov 27:ciae520. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. AKIYAMA MJ, Thornton K, Voyles N, Vincent L, et al
    Meeting People Where They Are: The Roles of Peer Navigation and Telemedicine for HCV Elimination.
    Clin Infect Dis. 2024 Nov 27:ciae521. doi: 10.1093.
    PubMed    
    
    
    
16. PERERA H, Keeshan A, Imsirovic H, Patern J, et al
    Rapid HCV Engagement and Treatment in Hospitalized Patients.
    Clin Infect Dis. 2024 Nov 21:ciae574. doi: 10.1093.
    PubMed    
    
    
    
17. EPSTEIN RL, Munroe S, Taylor LE, Duryea PR, et al
    Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study.
    Clin Infect Dis. 2024 Nov 13:ciae485. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
18. INZAULE S, Easterbrook P, Latona A, Ford NP, et al
    Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2024 Oct 3:ciae431. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. BIONDI BE, Munroe S, Lavarin C, Curtis MR, et al
    Racial and Ethnic Disparities in Hepatitis C Care in Reproductive-Aged Women With Opioid Use Disorder.
    Clin Infect Dis. 2024 Oct 2:ciae426. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
20. MARTIN-CARMONA J, Corma-Gomez A, Tellez F, Arenga-Barrios D, et al
    No impact of HIV coinfection on the mortality in patients with hepatitis C virus infection after sustained virological response.
    Clin Infect Dis. 2024 Sep 18:ciae473. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. MACISAAC MB, Papaluca T, McDonald L, Craigie A, et al
    Long-term outcomes of a decentralized, nurse-led, statewide model of care for hepatitis C among people in prison in Victoria, Australia.
    Clin Infect Dis. 2024 Sep 16:ciae471. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
22. FRIEDMAN JR, Abramovitz D, Skaathun B, Rangel G, et al
    Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.
    Clin Infect Dis. 2024 Jul 30:ciae372. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. FIERER DS, Carollo JR, Rodriguez-Caprio G, Radix A, et al
    Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City.
    Clin Infect Dis. 2024 Jul 18:ciae297. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
24. RUSS RK, Vandehei HM, Golovkina MI, Mogallapalli H, et al
    Hepatitis B-CpG vaccine series for healthcare workers who are hepatitis B vaccine nonresponders.
    Clin Infect Dis. 2024 Jun 17:ciae320. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. MIDGARD H, Malme KB, Finbraten AK, Dalgard O, et al
    Treatment completion and SVR in the context of HCV elimination: Time to let go of the reins?
    Clin Infect Dis. 2024 Jun 2:ciae298. doi: 10.1093.
    PubMed    
    
    
    May 2024
26. PAN CQ, Zhu L, Yu AS, Zhao Y, et al
    Tenofovir Alafenamide versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2024 May 28:ciae288. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. LO RE V 3RD, Price JC, Schmitt S, Terrault N, et al
    The Obstacle is the Way: Finding a Path to Hepatitis C Elimination.
    Clin Infect Dis. 2024 May 16:ciae231. doi: 10.1093.
    PubMed    
    
    
    
28. ZHANG HL, Mock M, Bushman L, Anderson PL, et al
    Cumulative tenofovir exposure among patients with human immunodeficiency virus/hepatitis B co-infection with differential viral suppression.
    Clin Infect Dis. 2024 May 3:ciae241. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
29. HOOD RB, Norris AH, Shoben A, Miller WC, et al
    Forecasting Hepatitis C Virus Status for Children in the United States: A Modeling Study.
    Clin Infect Dis. 2024 Apr 17:ciae157. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. CAFARDI JM, Lin HT, Lange L, Kelley L, et al
    Vertical Transmission of Hepatitis C Virus Among Women with a History of Injection Opioid Use.
    Clin Infect Dis. 2024 Apr 5:ciae177. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. SU WJ, Chen HL, Chen SF, Liu YL, et al
    Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing.
    Clin Infect Dis. 2024 Apr 2:ciae176. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
32. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
    Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
    Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. GREBELY J
    Point-of-care testing for hepatitis C infection: A critical building block for the foundation to achieve elimination.
    Clin Infect Dis. 2024 Mar 21:ciae156. doi: 10.1093.
    PubMed    
    
    
    
34. MCCARTNEY EM, Ralton L, Dawe J, Richmond J, et al
    Point of care testing for hepatitis C in the priority settings of mental health, prisons and drug & alcohol facilities - the PROMPt Study.
    Clin Infect Dis. 2024 Mar 21:ciae155. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
35. 
    Correction to: Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017-March 2020.
    Clin Infect Dis. 2024 Feb 23:ciad783. doi: 10.1093.
    PubMed    
    
    
    January 2024
36. LITWIN AH, Akiyama MJ
    US Veterans Health Administration Hepatitis C Virus (HCV) Program - A Model for National HCV Elimination though Patient-Centered Medical Homes.
    Clin Infect Dis. 2024 Jan 27:ciae028. doi: 10.1093.
    PubMed    
    
    
    
37. VARLEY CD, Lowy E, Cartwright EJ, Morgan TR, et al
    Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.
    Clin Infect Dis. 2024 Jan 27:ciae025. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
38. VINIKOOR MJ, Hamusonde K, Muula G, Asombang M, et al
    Long-term hepatitis B and liver outcomes among adults taking tenofovir-containing antiretroviral therapy for HBV/HIV coinfection in Zambia.
    Clin Infect Dis. 2023 Nov 24:ciad654. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. MIDGARD H, Malme KB, Pihl CM, Berg-Pedersen RM, et al
    Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial.
    Clin Infect Dis. 2023 Nov 22:ciad711. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. ROWAN SE, Wyles DL
    Don't put off until tomorrow what you can do today: Hospital admissions as an opportunity to treat hepatitis C.
    Clin Infect Dis. 2023 Nov 22:ciad712. doi: 10.1093.
    PubMed    
    
    
    October 2023
41. WONG RJ, Yang Z, Cheung R
    Disparities in Antiviral Treatment among Adults with Hepatitis B Cirrhosis: An Analysis of the National Veterans Affairs Cohort.
    Clin Infect Dis. 2023 Oct 9:ciad617. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
42. YANG J, Lo NC, Dankwa EA, Donnelly CA, et al
    Determining herd immunity thresholds for hepatitis A virus transmission to inform vaccination strategies among people who inject drugs in 16 U.S. States.
    Clin Infect Dis. 2023 Sep 21:ciad552. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.